NOD2 mutations and colorectal cancer - Where do we stand?

Area of Science:

• Genetics
• Oncology
• Immunology

Background:

• Colorectal cancer (CRC) presents a significant health burden, prompting research into its genetic underpinnings.
• The nucleotide-binding and oligomerization-domain containing 2 (NOD2) gene is a key focus due to its potential role in CRC susceptibility.
• Emerging evidence links NOD2 function to intestinal microbiota and mucosal immunity, suggesting a broader biological role.

Purpose of the Study:

• To review the current understanding of NOD2 mutations as genetic risk factors for chronic inflammation and CRC.
• To analyze the potential of NOD2 as a predictor of CRC phenotypes and therapeutic response.

Main Methods:

• Comprehensive literature review of studies investigating NOD2 polymorphisms and CRC risk.
• Analysis of experimental models and population-based studies, addressing conflicting findings and geographic variations.
• Evaluation of NOD2's role in relation to intestinal microbiota and mucosal immunity.

Main Results:

• Conflicting results exist in population-based studies linking NOD2 polymorphisms to increased CRC risk.
• Experimental models suggest deficient NOD2 function confers a communicable risk of colitis and CRC.
• Geographic variations in polymorphism frequency and study interpretations may limit definitive conclusions.

Conclusions:

• NOD2's role in CRC susceptibility requires further clarification, despite conflicting evidence.
• NOD2 may help identify individuals at genetic risk for CRC, potentially benefiting from early screening.
• Further research into NOD2's predictive value for CRC phenotypes and treatment response is warranted.